[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT8220954A0 - Composti attivi nel trattamento dell'ulcera e di sintomi allergici della pelle - Google Patents

Composti attivi nel trattamento dell'ulcera e di sintomi allergici della pelle

Info

Publication number
IT8220954A0
IT8220954A0 IT8220954A IT2095482A IT8220954A0 IT 8220954 A0 IT8220954 A0 IT 8220954A0 IT 8220954 A IT8220954 A IT 8220954A IT 2095482 A IT2095482 A IT 2095482A IT 8220954 A0 IT8220954 A0 IT 8220954A0
Authority
IT
Italy
Prior art keywords
ulcers
treatment
active compounds
allergic skin
skin symptoms
Prior art date
Application number
IT8220954A
Other languages
English (en)
Other versions
IT1190793B (it
Inventor
Moroni Adolfo
Original Assignee
Magis Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis Farmaceutici filed Critical Magis Farmaceutici
Priority to IT20954/82A priority Critical patent/IT1190793B/it
Publication of IT8220954A0 publication Critical patent/IT8220954A0/it
Priority to EP83100992A priority patent/EP0092647B1/en
Priority to DE8383100992T priority patent/DE3369135D1/de
Priority to AT83100992T priority patent/ATE24904T1/de
Priority to AU19760/83A priority patent/AU563738B2/en
Priority to JP58183243A priority patent/JPS6081177A/ja
Priority to CA000438490A priority patent/CA1223257A/en
Priority to US06/808,375 priority patent/US4613596A/en
Application granted granted Critical
Publication of IT1190793B publication Critical patent/IT1190793B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT20954/82A 1982-04-27 1982-04-27 Composti attivi nel trattamento dell'ulcera e sintomi allergici della pelle IT1190793B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT20954/82A IT1190793B (it) 1982-04-27 1982-04-27 Composti attivi nel trattamento dell'ulcera e sintomi allergici della pelle
EP83100992A EP0092647B1 (en) 1982-04-27 1983-02-03 New active compounds in the treatment of ulcers and skin allergy symptoms
DE8383100992T DE3369135D1 (en) 1982-04-27 1983-02-03 New active compounds in the treatment of ulcers and skin allergy symptoms
AT83100992T ATE24904T1 (de) 1982-04-27 1983-02-03 Verbindungen wirksam in der behandlung von magengeschwueren und von hautueberempfindlichkeitssymptomen.
AU19760/83A AU563738B2 (en) 1982-04-27 1983-09-29 Furan derivatives
JP58183243A JPS6081177A (ja) 1982-04-27 1983-10-03 潰瘍の治療に活性を有する化合物，この製法及びこれを用いた潰瘍治療剤
CA000438490A CA1223257A (en) 1982-04-27 1983-10-06 Compounds active in the treatment of ulcer and allergic skin symptoms
US06/808,375 US4613596A (en) 1982-04-27 1985-12-16 Amino methyl furans and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20954/82A IT1190793B (it) 1982-04-27 1982-04-27 Composti attivi nel trattamento dell'ulcera e sintomi allergici della pelle

Publications (2)

Publication Number Publication Date
IT8220954A0 true IT8220954A0 (it) 1982-04-27
IT1190793B IT1190793B (it) 1988-02-24

Family

ID=11174566

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20954/82A IT1190793B (it) 1982-04-27 1982-04-27 Composti attivi nel trattamento dell'ulcera e sintomi allergici della pelle

Country Status (8)

Country Link
US (1) US4613596A (it)
EP (1) EP0092647B1 (it)
JP (1) JPS6081177A (it)
AT (1) ATE24904T1 (it)
AU (1) AU563738B2 (it)
CA (1) CA1223257A (it)
DE (1) DE3369135D1 (it)
IT (1) IT1190793B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
IT1180185B (it) * 1984-06-12 1987-09-23 Magis Farmaceutici Derivato della ranitidina utile nel trattamento dell'ulcera
US4707550A (en) * 1986-04-28 1987-11-17 Ortho Pharmaceutical Corporation N-(substituted thienyl)-N'-(substituted piperazinyl)-ureas
IL87250A (en) * 1987-08-01 1993-06-10 Takeda Chemical Industries Ltd :-unsaturated amines, process for their preparation, insecticidal/ miticidal compositions containing them
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
DE69527786T2 (de) * 1994-05-18 2003-04-10 Nisshin Seifun Group Inc., Tokio/Tokyo Diaminomethyliden-derivate
WO1998005317A1 (en) * 1996-08-06 1998-02-12 Smithkline Beecham Corporation Il-8 receptor antagonists
US6177448B1 (en) 1996-08-06 2001-01-23 Smithkline Beecham Corporation IL-8 receptor antagonists
WO2000016766A1 (fr) * 1998-09-22 2000-03-30 Ishihara Sangyo Kaisha Ltd. Composition medicale contenant des derives de nitroetheneamine ou des sels de ces derives comme constituants actifs
PL211954B1 (pl) * 2002-01-11 2012-07-31 Sankyo Co Związek, kompozycja farmaceutyczna oraz zastosowanie kompozycji farmaceutycznej
NZ549162A (en) 2004-02-24 2009-12-24 Sankyo Co Amino-pyrrol alcohol compounds
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
NL8000869A (nl) * 1979-02-16 1980-08-19 Eisai Co Ltd Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan.
EP0057981A3 (en) * 1981-02-09 1982-08-25 Beecham Group Plc Aromatic compounds, processes for their preparation and their use

Also Published As

Publication number Publication date
DE3369135D1 (en) 1987-02-19
US4613596A (en) 1986-09-23
AU1976083A (en) 1985-04-04
EP0092647A1 (en) 1983-11-02
AU563738B2 (en) 1987-07-23
EP0092647B1 (en) 1987-01-14
CA1223257A (en) 1987-06-23
JPH0429671B2 (it) 1992-05-19
IT1190793B (it) 1988-02-24
ATE24904T1 (de) 1987-01-15
JPS6081177A (ja) 1985-05-09

Similar Documents

Publication Publication Date Title
IT1211852B (it) Composizione di collirio isotonico umettante
PT83934B (pt) Emplastros aperfeicoados dermicos e transdermicos multicompartimentados
EP0273202A3 (en) Additives enhancing topical actions of therapeutic agents
IT8220954A0 (it) Composti attivi nel trattamento dell'ulcera e di sintomi allergici della pelle
IT1153294B (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle
KR880700671A (ko) 포유동물에서 상피창상의 치유향상방법
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
DK245686A (da) Hidtil ukendt behandling
IT1173329B (it) Procedimento per la trasformazione quantitativa di teicoplanina a2 fattore 1 in teicoplanina a2 fattore 3
ES557720A0 (es) Procedimiento de producir agentes terapeuticos y profilacticos para ulceras pepticas
DK293086D0 (da) Hidtil ukendt behandling
IT7967029A0 (it) Amminoderivati della pirazolo i 5 as triazina particolarmente utili in terapia e procedimento per la loropreparazione
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
DK135486A (da) Efterbehandlet protetisk organ
FR2588756B1 (fr) Composition pour le traitement des cheveux
ES535697A0 (es) Perfeccionamientos en la fabricacion de microcapsulas
IT8467183A0 (it) Composizione farmaceutica per la profilassi ed il trattamento della arteriosclerosi
FR2594690B1 (fr) Compositions regeneratrices et stimulantes du derme
IT8421358A0 (it) Derivato della ranitidina utile nel trattamento dell'ulcera.
IT8348665A0 (it) Trattamento dei disturbi allergici
IT1192377B (it) Struttura schermante per assicurare l'abbronzatura della pelle senza inconvenienti e disagi
IT8211557V0 (it) Struttura schermante per assicurare l'abbronzatura della pelle senza inconvenienti e disagi
TR22606A (tr) Pissularin adsorpsiyon asamah tesislerde aritilma yoentemi
IT8420712A1 (it) "Trattamento delle infezioni erpetiche"
TR22363A (tr) Alkillestirilmis antrakinonlarin aritilmasi